Literature DB >> 7448767

Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180.

H Masuno, N Yamasaki, H Okuda.   

Abstract

A lipolytic substance in the ascites fluid of mice with Sarcoma 180, called toxohormone-L, was purified and characterized. The lipolytic activity of toxohormone-L was measured in vitro using rat adipose tissue slices. Toxohormone-L, purified approximately 90-fold from the ammonium sulfate fraction, gave a single band on polyacrylamide gel electrophoresis. Its molecular weight was about 75,000, and its isoelectric point was 4.7. Toxohormone-L is heat labile and nondialyzable, but, on its digestion with trypsin, an active fragment that was heat stable and dialyzable was produced. Toxohormone-L is a protein and is also present in the ascites fluid of patients with hepatoma and Grawitz's tumor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7448767

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Cancer cachexia.

Authors:  M J Tisdale; S A Beck
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

2.  Turnover and fate of plasma free fatty acids in briefly-fasted lymphoma-bearing mice.

Authors:  N Baker; M Gan-Elepano; B A Guthrie; J F Mead
Journal:  Lipids       Date:  1989-12       Impact factor: 1.880

3.  Lipid metabolism in cancer cachexia.

Authors:  H D Mulligan; S A Beck; M J Tisdale
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

Review 4.  Cancer cachexia.

Authors:  M J Tisdale
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

5.  Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.

Authors:  P Groundwater; S A Beck; C Barton; C Adamson; I N Ferrier; M J Tisdale
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

6.  Alterations in serum lipolytic activity of cancer patients with response to therapy.

Authors:  S A Beck; P Groundwater; C Barton; M J Tisdale
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

7.  Lipid mobilising factors specifically associated with cancer cachexia.

Authors:  S A Beck; M J Tisdale
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

8.  Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer.

Authors:  L Baró; J C Hermoso; M C Núñez; J A Jiménez-Rios; A Gil
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

9.  Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.

Authors:  A Chaudry; S McClinton; L E Moffat; K W Wahle
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

10.  Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.

Authors:  M J Tisdale; R A Brennan
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.